Last reviewed · How we verify
Bupivicaine
Bupivicaine is a Small molecule drug developed by University of Colorado, Denver. It is currently FDA-approved. Also known as: Bupivicaine, Peripheral Nerve Injection, marcaine, Marcaine.
Bupivacaine is a medication used to decrease sensation in a specific small area, typically injected around a nerve or into the spinal canal's epidural space. It works by blocking the sodium channel protein type IV alpha subunit, a mechanism that is classified as a blocker.
At a glance
| Generic name | Bupivicaine |
|---|---|
| Also known as | Bupivicaine, Peripheral Nerve Injection, marcaine, Marcaine, Marcain |
| Sponsor | University of Colorado, Denver |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Regional Nerve Blocks to Improve Analgesia and Recovery in Older Adults Undergoing Spinal Fusion (EARLY_PHASE1)
- Comparison Between Tranversus Abdominis Plane (TAP) Block With Only Bupivacaine and TAP Block With Bupivacaine Plus Ketamine in Reducing Postoperative Pain After Total Abdominal Hystrectomy (PHASE1, PHASE2)
- COMFORT Trial: Complex Obstetric Management With Focused Regional Transversus Abdominis Plane Block (PHASE4)
- Total Knee Arthroplasty Infiltration Study for Postoperative Analgesia (PHASE2)
- Evaluation of the Efficacy and Safety of HTX-011 for Postoperative Analgesia Following Abdominoplasty Surgery (PHASE2)
- TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant (PHASE4)
- Enhanced Recovery After Surgery (ERAS) in Live Donor Kidney Transplant Recipients (PHASE4)
- Post Operative Infusion Pump Pain Study (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Bupivicaine CI brief — competitive landscape report
- Bupivicaine updates RSS · CI watch RSS
- University of Colorado, Denver portfolio CI
Frequently asked questions about Bupivicaine
What is Bupivicaine?
Who makes Bupivicaine?
Is Bupivicaine also known as anything else?
What development phase is Bupivicaine in?
Related
- Manufacturer: University of Colorado, Denver — full pipeline
- Therapeutic area: All drugs in Other
- Also known as: Bupivicaine, Peripheral Nerve Injection, marcaine, Marcaine, Marcain
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing